Dual OTC/Rx Spending Under Part D
Both the Medicare program and patients often pay more for nonprescription drugs that are purchased as prescriptions under Part D than if purchased OTC, researchers
Both the Medicare program and patients often pay more for nonprescription drugs that are purchased as prescriptions under Part D than if purchased OTC, researchers
The largest U.S. primary care delivery model ever tested, the Comprehensive Primary Care Plus (CPC+) met some goals related to the theory of change and
Medicare Part D plan sponsors reimbursed pharmacies for generic drugs at excessively high rates during 2021, according to a study of reimbursement rates, which were
Reducing drug prices through increased regulation of pharmacy benefit managers (PBMs) is a priority for the U.S. Congress, according to the authors of a Perspective
Payments from the pharmaceutical industry are associated with oncologists’ prescribing of cancer drugs of questionable benefit, according to a cohort study of fee-for-service Medicare claims.
After presenting the case of an older adult who had to prioritize treatment of severe tooth pain over medications for high blood pressure, authors write,
Launched by CMS in 2017 and funded through 2021, the Million Hearts Model successfully reduced first-time myocardial infarctions (MIs) and strokes in Medicare beneficiaries aged
Higher costs of long-term medications for children were associated with small reductions in adherence by parents, a cohort study shows. “Health care systems should consider
A position paper from 6 medical organizations presents concerns with the CMS Severe Sepsis/Septic Shock Management Bundle (SEP-1), which was introduced as a pay-for-reporting measure
Approved by the FDA in July 2023, the first over-the-counter (OTC) daily oral contraceptive pill Opill (norgestrel) “could dramatically improve family planning” in the United